Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol

Cameron Meyer-Mueller; Cynthia Nicholson; Ingrid Polcari; Christina Boull; Sheilagh Maguiness

doi:10.1111/pde.14933

Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol

Cameron Meyer-Mueller, Cynthia Nicholson, Ingrid Polcari, Christina Boull, Sheilagh Maguiness

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

For infantile hemangiomas (IH) requiring treatment, including those in high-risk locations or in the setting of ulceration, oral propranolol is first-line therapy. Here, we present three cases of infantile hemangioma with worsening ulceration following initiation or escalation of oral propranolol at standard doses.

Original language	English (US)
Pages (from-to)	255-259
Number of pages	5
Journal	Pediatric Dermatology
Volume	39
Issue number	2
DOIs	https://doi.org/10.1111/pde.14933
State	Published - Mar 1 2022

Bibliographical note

Publisher Copyright:
© 2022 Wiley Periodicals LLC.

Keywords

hemangioma/complications
hemangioma/drug therapy
propranolol/administration and dosage
skin ulcer/drug therapy
treatment outcome
Administration, Oral
Humans
Infant
Treatment Outcome
Hemangioma, Capillary/drug therapy
Adrenergic beta-Antagonists/adverse effects
Propranolol/adverse effects
Hemangioma/drug therapy
Skin Neoplasms/drug therapy

PubMed: MeSH publication types

Case Reports

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1111/pde.14933

Find It

Find It at U of M Libraries

Cite this

@article{b7bfb20d7c2f4903a96480e2b59d219c,

title = "Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol",

abstract = "For infantile hemangiomas (IH) requiring treatment, including those in high-risk locations or in the setting of ulceration, oral propranolol is first-line therapy. Here, we present three cases of infantile hemangioma with worsening ulceration following initiation or escalation of oral propranolol at standard doses.",

keywords = "hemangioma/complications, hemangioma/drug therapy, propranolol/administration and dosage, skin ulcer/drug therapy, treatment outcome, Administration, Oral, Humans, Infant, Treatment Outcome, Hemangioma, Capillary/drug therapy, Adrenergic beta-Antagonists/adverse effects, Propranolol/adverse effects, Hemangioma/drug therapy, Skin Neoplasms/drug therapy",

author = "Cameron Meyer-Mueller and Cynthia Nicholson and Ingrid Polcari and Christina Boull and Sheilagh Maguiness",

note = "Publisher Copyright: {\textcopyright} 2022 Wiley Periodicals LLC.",

year = "2022",

month = mar,

day = "1",

doi = "10.1111/pde.14933",

language = "English (US)",

volume = "39",

pages = "255--259",

journal = "Pediatric Dermatology",

issn = "0736-8046",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol

AU - Meyer-Mueller, Cameron

AU - Nicholson, Cynthia

AU - Polcari, Ingrid

AU - Boull, Christina

AU - Maguiness, Sheilagh

PY - 2022/3/1

Y1 - 2022/3/1

N2 - For infantile hemangiomas (IH) requiring treatment, including those in high-risk locations or in the setting of ulceration, oral propranolol is first-line therapy. Here, we present three cases of infantile hemangioma with worsening ulceration following initiation or escalation of oral propranolol at standard doses.

AB - For infantile hemangiomas (IH) requiring treatment, including those in high-risk locations or in the setting of ulceration, oral propranolol is first-line therapy. Here, we present three cases of infantile hemangioma with worsening ulceration following initiation or escalation of oral propranolol at standard doses.

KW - hemangioma/complications

KW - hemangioma/drug therapy

KW - propranolol/administration and dosage

KW - skin ulcer/drug therapy

KW - treatment outcome

KW - Administration, Oral

KW - Humans

KW - Infant

KW - Treatment Outcome

KW - Hemangioma, Capillary/drug therapy

KW - Adrenergic beta-Antagonists/adverse effects

KW - Propranolol/adverse effects

KW - Hemangioma/drug therapy

KW - Skin Neoplasms/drug therapy

UR - http://www.scopus.com/inward/record.url?scp=85124708945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124708945&partnerID=8YFLogxK

U2 - 10.1111/pde.14933

DO - 10.1111/pde.14933

M3 - Article

C2 - 35178750

AN - SCOPUS:85124708945

SN - 0736-8046

VL - 39

SP - 255

EP - 259

JO - Pediatric Dermatology

JF - Pediatric Dermatology

IS - 2

ER -

Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this